Charles River Laboratories | Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Agilent USD 871M 28M 2025-09
Align Technology USD 363.97M 7.48M 2025-12
Bio-Rad Laboratories USD 309.6M 3.3M 2025-09
Bruker USD 528M 46.9M 2025-12
Cardinal Health USD 63.36B 1.57B 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Cigna USD 63.37B 1.93B 2025-09
Concord Medical Services Hldg CNY 321.94M 69.56M 2023-06
CVS Health USD 92.13B 3.06B 2025-12
Danaher USD 2.87B 342M 2025-12
Dentsply International USD 463M 17M 2025-09
Elevance Health USD 38.07B 75M 2025-12
Galapagos EUR 84.73M 80.02M 2025-09
Hologic USD 463.7M 5.1M 2025-12
Humana USD 26.54B 1.15B 2025-03
Illumina USD 400M 49M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Intrexon USD 1.01M 344K 2024-06
IQVIA Holdings USD 3.24B 518M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Lonza CHF 2.28B 189M 2025-06
McKesson USD 102.47B 2.86B 2025-12
Merck EUR 2.1B 123M 2025-09
Mettler Toledo International USD 473.97M 33.71M 2025-12
Novartis USD 3.54B 217M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Quest Diagnostics USD 1.93B 27M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12
United Therapeutics USD 100.9M 74.3M 2025-09
UnitedHealth USD 92.52B 920M 2025-09
Veradigm USD 68.49M 2.93M 2022-09
Waters USD 374.94M 47.13M 2025-12
West Pharmaceutical Services USD 501.1M 9.2M 2025-12


Charles River Laboratories Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.